3.4. CD8+ T cells with Murinized Transgenic HA-1–Specific TCRs and CRISPR/Cas Knockout of Endogenous TCR Showed Specific Lysis of PBMC from HA-1+ Patients with Various Hematological Malignancies. The gene discussed is CD8A; the disease is hematologic disorder.